| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9760c2326aa9ca3972954c6cb1612024 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-175 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-543 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2022-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69925b79b55b901eea5db263e54ffff7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50c5cab448ca112bd939b4a8f34784f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dba0dd9d7d6647025773e9d1dcb56b2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05365aa668135f6b506bc1d0ec017416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18b80d1347b8ae2845771522dc3dc923
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b09239f4f40bb08c078eb0b14c5189ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afd6a3753b5c0dbff2c6fcbdb28b501f |
| publicationDate |
2022-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-115057925-A |
| titleOfInvention |
A kind of monoclonal antibody against Akabane disease virus and its application |
| abstract |
The invention discloses a monoclonal antibody against Akabane disease virus and an application thereof, and relates to the field of biotechnology. The heavy chain of the monoclonal antibody is shown in SEQ ID NO.1, and the light chain is shown in SEQ ID NO.3. The present invention also provides the application of the Akabane disease virus monoclonal antibody in the preparation of Akabane disease virus detection products. The monoclonal antibody provided by the present invention can specifically recognize the AKAVN protein, and can provide technical support for the preparation of Akabane disease detection reagents or kits. The invention uses the purified AKAVN protein as the coating antigen and the monoclonal antibody 1C5 obtained by using the AKAVN protein as the immunogen as the labeled antibody to construct a blocking ELISA detection kit for Akabane disease virus, so as to meet the requirements of the current grass-roots animal epidemic prevention and quarantine. and testing requirements for entry and exit animal quarantine. |
| priorityDate |
2022-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |